Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry. 2022

Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
Unit on Neuromodulation and Synaptic Integration, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. hugo.tejeda@nih.gov.

Cortical circuits control a plethora of behaviors, from sensation to cognition. The cortex is enriched with neuropeptides and receptors that play a role in information processing, including opioid peptides and their cognate receptors. The dynorphin (DYN)/kappa-opioid receptor (KOR) system has been implicated in the processing of sensory and motivationally-charged emotional information and is highly expressed in cortical circuits. This is important as dysregulation of DYN/KOR signaling in limbic and cortical circuits has been implicated in promoting negative affect and cognitive deficits in various neuropsychiatric disorders. However, research investigating the role of this system in controlling cortical circuits and computations therein is limited. Here, we review the (1) basic anatomy of cortical circuits, (2) anatomical architecture of the cortical DYN/KOR system, (3) functional regulation of cortical synaptic transmission and microcircuit function by the DYN/KOR system, (4) regulation of behavior by the cortical DYN/KOR system, (5) implications for the DYN/KOR system for human health and disease, and (6) future directions and unanswered questions for the field. Further work elucidating the role of the DYN/KOR system in controlling cortical information processing and associated behaviors will be of importance to increasing our understanding of principles underlying neuropeptide modulation of cortical circuits, mechanisms underlying sensation and perception, motivated and emotional behavior, and cognition. Increased emphasis in this area of study will also aid in the identification of novel ways to target the DYN/KOR system to treat neuropsychiatric disorders.

UI MeSH Term Description Entries
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D004399 Dynorphins A class of opioid peptides including dynorphin A, dynorphin B, and smaller fragments of these peptides. Dynorphins prefer kappa-opioid receptors (RECEPTORS, OPIOID, KAPPA) and have been shown to play a role as central nervous system transmitters. Dynorphin,Dynorphin (1-17),Dynorphin A,Dynorphin A (1-17)
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017473 Receptors, Opioid, kappa A class of opioid receptors recognized by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins. Opioid Receptors, kappa,Receptors, kappa,Receptors, kappa Opioid,kappa Receptors,kappa Opioid Receptor,kappa Receptor,Opioid Receptor, kappa,Receptor, kappa,Receptor, kappa Opioid,kappa Opioid Receptors
D018847 Opioid Peptides The endogenous peptides with opiate-like activity. The three major classes currently recognized are the ENKEPHALINS, the DYNORPHINS, and the ENDORPHINS. Each of these families derives from different precursors, proenkephalin, prodynorphin, and PRO-OPIOMELANOCORTIN, respectively. There are also at least three classes of OPIOID RECEPTORS, but the peptide families do not map to the receptors in a simple way. Opiates, Endogenous,Endogenous Opiates,Opiate Peptides,Opioid Peptide,Peptide, Opioid,Peptides, Opiate,Peptides, Opioid

Related Publications

Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
January 2022, Frontiers in systems neuroscience,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
January 2012, Frontiers in molecular neuroscience,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
January 2000, DNA and cell biology,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
July 1997, Pharmacology, biochemistry, and behavior,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
May 2010, Peptides,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
March 2007, Life sciences,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
August 2017, Alcoholism, clinical and experimental research,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
January 1983, Peptides,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
January 2022, Frontiers in pharmacology,
Hugo A Tejeda, and Huikun Wang, and Rodolfo J Flores, and Hector E Yarur
August 2013, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Copied contents to your clipboard!